• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗内脏利什曼病是否需要递增剂量的两性霉素B?

Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis?

作者信息

Thakur C P, Sinha G P, Barat D, Singh R K

机构信息

Patna Medical College and Hospital, India.

出版信息

Ann Trop Med Parasitol. 1994 Aug;88(4):365-70. doi: 10.1080/00034983.1994.11812878.

DOI:10.1080/00034983.1994.11812878
PMID:7979623
Abstract

One-hundred-and-twenty visceral leishmaniasis patients, all with demonstrable splenic amastigotes after treatment with sodium stibogluconate and pentamidine, were treated with amphotericin B. The patients were allocated into two equal groups matched by age and sex. Patients in one group received amphotericin B in the traditional incremental dose regimen, i.e. 0.05, 0.10, 0.25, 0.50 and 1.0 mg/kg body weight on days 1, 2, 3, 4, and > 4, respectively. Patients in the other group received amphotericin B at a constant 1 mg/kg bodyweight per day from day 1. Each of the 120 patients received a total dose of 20 mg/kg bodyweight. By the end of treatment the incidence of infusion-related toxicities, such as rigor and fever, and of renal toxicities, such as elevated serum creatinine and low serum potassium, was the same in both groups (P > 0.05). The two treatment regimens were also equally effective; every patient was cured and none relapsed within 6 months' follow-up. It is therefore recommended that amphotericin B be given as the full optimal dose (1 mg/kg) from day 1. There seems no advantage in the incremental regimen; not only does it 'waste' 4 days before the optimal dose is reached but it is more expensive and may encourage the development of drug resistance.

摘要

120例内脏利什曼病患者在用葡萄糖酸锑钠和喷他脒治疗后脾脏均有可检测到的无鞭毛体,对这些患者采用两性霉素B进行治疗。患者按年龄和性别匹配被分为两组。一组患者采用传统的递增剂量方案接受两性霉素B治疗,即分别在第1、2、3、4天及4天以后给予0.05、0.10、0.25、0.50和1.0mg/kg体重的药物。另一组患者从第1天起每天按1mg/kg体重的固定剂量接受两性霉素B治疗。120例患者每人接受的总剂量均为20mg/kg体重。治疗结束时,两组中输注相关毒性(如寒战和发热)以及肾毒性(如血清肌酐升高和血清钾降低)的发生率相同(P>0.05)。两种治疗方案同样有效;所有患者均治愈,在6个月的随访期内无一例复发。因此,建议从第1天起就给予两性霉素B最佳全剂量(1mg/kg)。递增方案似乎没有优势;它不仅在达到最佳剂量之前“浪费”了4天时间,而且成本更高,还可能促使耐药性的产生。

相似文献

1
Are incremental doses of amphotericin B required for the treatment of visceral leishmaniasis?治疗内脏利什曼病是否需要递增剂量的两性霉素B?
Ann Trop Med Parasitol. 1994 Aug;88(4):365-70. doi: 10.1080/00034983.1994.11812878.
2
Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases.采用新型给药方式及预防措施的两性霉素B脱氧胆酸盐治疗内脏利什曼病:938例病例研究
Trans R Soc Trop Med Hyg. 1999 May-Jun;93(3):319-23. doi: 10.1016/s0035-9203(99)90037-8.
3
Amphotericin B in resistant kala-azar in Bihar.两性霉素B治疗比哈尔邦抗药性黑热病
Natl Med J India. 1993 Mar-Apr;6(2):57-60.
4
Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison.两性霉素B治疗黑热病的每日给药方案与隔日给药方案:一项随机对照比较
Bull World Health Organ. 1994;72(6):931-6.
5
Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.脂质体两性霉素B(安必素)在地方性流行发展中国家治疗内脏利什曼病的疗效和安全性。
Bull World Health Organ. 1998;76(1):25-32.
6
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.印度内脏利什曼病短程多药治疗与标准治疗的比较:一项开放标签、非劣效性、随机对照试验。
Lancet. 2011 Feb 5;377(9764):477-86. doi: 10.1016/S0140-6736(10)62050-8. Epub 2011 Jan 20.
7
Comparison of regimens of amphotericin B deoxycholate in kala-azar.去氧胆酸两性霉素B治疗黑热病的方案比较。
Indian J Med Res. 1996 May;103:259-63.
8
Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride.用生理盐水和氯化钾补充两性霉素 B 以改善黑热病治疗效果。
Am J Trop Med Hyg. 2010 Nov;83(5):1040-3. doi: 10.4269/ajtmh.2010.10-0255.
9
Amphotericin B therapy in kala-azar.两性霉素B治疗黑热病。
J Indian Med Assoc. 1993 Apr;91(4):91-3.
10
Amphotericin B therapy in children with visceral leishmaniasis: daily vs. alternate day, a randomized trial.两性霉素 B 治疗内脏利什曼病患儿:每日与隔日治疗的随机试验。
J Trop Pediatr. 2010 Oct;56(5):321-4. doi: 10.1093/tropej/fmp132. Epub 2010 Jan 11.

引用本文的文献

1
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective.从公共卫生角度看印度内脏利什曼病治疗方案的当前挑战
Infect Dis Poverty. 2016 Mar 8;5:19. doi: 10.1186/s40249-016-0112-2.
2
Species-directed therapy for leishmaniasis in returning travellers: a comprehensive guide.针对归国旅行者利什曼病的物种导向疗法:综合指南。
PLoS Negl Trop Dis. 2014 May 1;8(5):e2832. doi: 10.1371/journal.pntd.0002832. eCollection 2014 May.
3
Therapeutic options for visceral leishmaniasis.内脏利什曼病的治疗选择。
Drugs. 2013 Nov;73(17):1863-88. doi: 10.1007/s40265-013-0133-0.
4
Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.婴儿利什曼原虫所致内脏利什曼病的治疗:两性霉素B脂质体疗效的实验评估
Antimicrob Agents Chemother. 1996 May;40(5):1214-8. doi: 10.1128/AAC.40.5.1214.